Life Healthcare Group Holdings Management
Management criteria checks 2/4
Life Healthcare Group Holdings' CEO is Peter Wharton-Hood, appointed in Sep 2020, has a tenure of 5.42 years. total yearly compensation is ZAR47.61M, comprised of 20.1% salary and 79.9% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth ZAR33.83M. The average tenure of the management team and the board of directors is 5.2 years and 4.4 years respectively.
Key information
Peter Wharton-Hood
Chief executive officer
R47.6m
Total compensation
| CEO salary percentage | 20.10% |
| CEO tenure | 5.4yrs |
| CEO ownership | 0.2% |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Expanding NeuraCeq Sales And Southern Africa Hospitals Will Improve Future Market Position
Expansion in Southern Africa and investments in high-margin imaging services are expected to significantly boost revenue and future earnings.Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
Aug 05
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17
May 30Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital
Apr 20Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Mar 18Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends
Dec 24We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings
Nov 24Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25
Nov 23An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued
Sep 14Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Aug 15Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)
Jul 31Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?
May 19Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital
Apr 28An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued
Feb 08There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
Jan 25With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For
Jan 08Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?
Nov 28Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?
Oct 19Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return
Aug 16We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt
Jul 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | R48m | R10m | -R2b |
| Jun 30 2025 | n/a | n/a | -R2b |
| Mar 31 2025 | n/a | n/a | -R924m |
| Dec 31 2024 | n/a | n/a | R531m |
| Sep 30 2024 | R40m | R9m | R1b |
| Jun 30 2024 | n/a | n/a | R1b |
| Mar 31 2024 | n/a | n/a | R1b |
| Dec 31 2023 | n/a | n/a | R1b |
| Sep 30 2023 | R19m | R9m | R1b |
| Mar 31 2023 | n/a | n/a | R1b |
| Dec 31 2022 | n/a | n/a | R1b |
| Sep 30 2022 | R18m | R8m | R1b |
| Mar 31 2022 | n/a | n/a | R2b |
| Dec 31 2021 | n/a | n/a | R2b |
| Sep 30 2021 | R18m | R8m | R2b |
| Mar 31 2021 | n/a | n/a | R629m |
| Dec 31 2020 | n/a | n/a | R668m |
| Sep 30 2020 | R8m | R641k | R706m |
Compensation vs Market: Peter's total compensation ($USD2.98M) is above average for companies of similar size in the ZA market ($USD1.41M).
Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.
CEO
Peter Wharton-Hood (59 yo)
Mr. Peter Gerard Wharton-Hood, (BCom (Hons) (Wits), CA(SA), AMP (Harvard)), serves as Chief Executive Officer at Life Healthcare Group Holdings since December 2024. He serves as the Group Chief Executive O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 5.4yrs | R47.61m | 0.21% ZAR 33.8m | |
| CFO & Executive Director | 12.7yrs | R31.29m | 0.19% ZAR 30.7m | |
| Chief Operations Officer | 1.8yrs | no data | no data | |
| Chief Information Officer | no data | no data | no data | |
| Chief Strategy & Growth Officer and Executive Head of Investor Relations | no data | R10.37m | 0.0033% ZAR 528.6k | |
| Chief People Officer | 4.9yrs | no data | no data | |
| Chief Nurse Officer | no data | no data | no data | |
| Chief Medical Officer | no data | no data | no data | |
| Chief Actuary & Risk Officer | no data | no data | no data | |
| Group Company Secretary | 4.9yrs | no data | no data | |
| Non-Executive Director of Life UK | 7.7yrs | R16.34m | no data | |
| Non-Executive Director of Life UK | no data | no data | no data |
Experienced Management: LHC's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | no data | R47.61m | 0.21% ZAR 33.8m | |
| CFO & Executive Director | 12.7yrs | R31.29m | 0.19% ZAR 30.7m | |
| Independent Non-Executive Director | 8.6yrs | R1.21m | no data | |
| Lead Independent Non-Executive Director | 8.6yrs | R1.23m | no data | |
| Independent Non-Executive Director | 4.4yrs | R1.29m | no data | |
| Independent Non-Executive Director | 3.5yrs | R2.72m | no data | |
| Independent Non-Executive Director | 12.1yrs | R781.00k | no data | |
| Independent Non-Executive Chairman | 5.8yrs | R2.20m | 0.00070% ZAR 113.5k | |
| Independent Non-Executive Director | 2.8yrs | R1.28m | no data | |
| Independent Non-Executive Director | 3yrs | R1.14m | no data | |
| Independent Non-Executive Director | 1.5yrs | R641.00k | no data | |
| Independent Non-Executive Director | 1.5yrs | R589.00k | no data |
Experienced Board: LHC's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/16 21:40 |
| End of Day Share Price | 2026/02/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Life Healthcare Group Holdings Limited is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rendani Magalela | Absa Bank Limited |
| Sean Ungerer | Arqaam Capital Research Offshore S.A.L. |
| Simon Mather | Barclays |